Skip to main content
. 2013 Dec 18;29(3):387–393. doi: 10.1007/s00384-013-1807-5

Table 1.

Characteristics of the investigated groups (10 years if diverticulosis and longer) and results of the investigation at 12 months of follow-up

All patients Treatment group Placebo group p value
Number of patients 52 30 22
Gender (female/male) 30/22 17/13 13/9
Mean age of patients (years) 64.2 63.7 64.7 ns
SD 6.7 6.09 7.65
Median 63.5 63 64
Duration of diverticulosis (years) 9.9 10.47 9.32 ns
SD 4.46 4.18 4.82
Median 10 8.5 10
Clinical symptoms of diverticulitis: acute left lower quadrant pain, tenderness, fever (>3 °8C) or leukocytosis (WBC > 12,000/mm3), n (%) 9 (17.3) 2 (6.7) 7 (31.8) 0.0425
Abdominal ultrasound examinations for suspected diverticulitis, n (%) 6 (11.5) 1 (3.3) 5 (22.7) 0.0229
Diagnoses of diverticulitis in abdominal US, n (%) 6 (11.5) 1 (3.3) 5 (22.7)
CT abdomen for suspected diverticulitis, n (%) 3 (5.8) 1 (3.3) 2 (9) ns (low number of events)
Diagnoses of diverticulitis in CT abdomen, n (%) 3 (5.8) 1 (3.3) 2 (9)
Hospitalizations for diverticulitis, n (%) 4 (7.7) 1 (3.3) 3 (13.6) ns (low number of events)
Surgery (Hartmann's procedure) because of diverticulitis, n (%) 1 (1.9) 0 (0) 1 (4.5) ns (low number of events)
Subjective evaluation of the patients (positive answer to the question: Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?), n (%) 22 (42.3) 17 (56.7) 5 (22.7) 0.0143
Number of adverse events, n (%) 0 (0) 0 (0) 0 (0) ns (low number of events)

ns not significant